On Friday, Shares of Citigroup Inc (NYSE:C), gained 2.91% to $50.56.
Citigroup has hired two investment bankers focused on giving advice to retail companies from Credit Suisse, people familiar with the matter said on Friday, according to Reuters.
Managing director Brian Anton and director Hugh Paisley join former colleague Douglas Trauber who left Credit Suisse to join Citigroup as global co-head of retail in August, the people said, asking not to be named because the moves have not been declared.
Representatives from Citigroup and Credit Suisse declined to comment. Anton and Paisley could not be reached for comment. Reuters Reports
Citigroup Inc. (Citi) is a financial services holding company, whose businesses provide consumers, corporations, governments and institutions with financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, trade and securities services, and wealth management. The Company operates through two primary business segments: Citicorp and Citi Holdings.
Shares of Comcast Corporation(NASDAQ:CMCSA), declined -0.49% to $56.54, during its last trading session.
Comcast Corporation is buying a majority stake in theme park operator Universal Studios’ Japanese arm for $1.5 billion, according to AP.
Cable operator Comcast, which owns NBCUniversal, will have 51 percent ownership of the business.
Universal Studios Japan, which opened in Osaka in 2001, has many of the company’s well-known attractions, in addition to rides and shows geared specifically toward the Japanese market.
NBCUniversal CEO Steve Burke said in a written statement on Monday that the acquisition will assist to expand the company’s theme park business around the world. AP Reports
Comcast Corporation is a media and technology company. The Company has two primary businesses, Comcast Cable and NBCUniversal. The Company’s business line comprises five segments: Cable Communications; Cable Networks; Broadcast Television; Filmed Entertainment, and Theme Parks.
Shares of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), declined -2.54% to $59.40, during its last trading session.
Teva Pharmaceutical Industries declared recently the approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) of once-daily COPAXONE® (glatiramer acetate injection) 20mg injection for the prevention of relapse of multiple sclerosis . The product will be commercialized in Japan by Takeda Pharmaceutical Company Limited (Takeda).
In Japan, glatiramer acetate was developed as an Unapproved New Drug by Teva Pharmaceutical K.K., a wholly owned partner of Teva, at the request of the MHLW. In March, 2013, Takeda and Teva signed a contract in which Teva granted Takeda the right to commercialize COPAXONE® in Japan.
The Japanese approval for COPAXONE® is based on the safety and efficacy results of an open-label, 52-week clinical trial conducted by Teva Pharmaceutical K.K. in patients with relapsing-remitting multiple sclerosis in Japan in addition to the pivotal trial data sets used for approvals in other countries.
Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical and drug company. The Company’s generic products cover almost every major therapeutic area. The Company operates its business in two segments: Generic medicines, which manufactures and sells generic pharmaceutical products in several dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams, and Specialty medicines, which delivers solutions to patients and providers via medicines, devices and services.
Finally, SYSCO Corporation, (NYSE:SYY), ended its last trade with 0.05% gain, and closed at $39.73.
At its 2015 Investor Day, Sysco Corporation (SYY) senior executives recently presented a three-year planned business plan designed to improve the customer experience, enhance associate engagement and deliver strong financial results to drive shareholder value over time.
“Sysco has a substantial market opportunity, a sound strategy, great people and a recent record of improving financial results,” said Bill DeLaney, Sysco president and chief executive officer. “Over the past few months, our executive team has developed a robust three-year plan that targets at least $400 million in annualized operating income growth and a 15 percent return on invested capital by Fiscal 2018. This plan leverages a variety of new capabilities and initiatives developed over the past several years that together provide a strong foundation for ongoing value creation. We are confident that this plan is the right one for Sysco shareholders, customers and associates, and we look forward to delivering on these commitments.”
Sysco anticipates to achieve its new operating income and return on invested capital targets by accelerating local case growth, improving gross margins, leveraging its end-to-end supply chain, reducing administrative costs and generating more than $1 billion in free cash flow per year.
Sysco Corporation (Sysco) along with its subsidiaries and divisions, is a North American distributor of food and related products primarily to the foodservice or food-away-from-home industry. The Company provides products and related services to approximately 425,000 customers, including restaurants, healthcare and educational facilities, lodging establishments and other foodservice customers. Sysco provides food and related products to the foodservice or food-away-from-home industry.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
